These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18547977)

  • 1. Modern treatment options for elderly patients with multiple myeloma.
    Görner M; Späth-Schwalbe E;
    Onkologie; 2008 Jun; 31(6):335-42. PubMed ID: 18547977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing multiple myeloma in the elderly: are we making progress?
    Quach H; Prince HM; Spencer A
    Expert Rev Hematol; 2011 Jun; 4(3):301-15. PubMed ID: 21668395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontline treatment in elderly patients with multiple myeloma.
    Facon T; San Miguel J; Mateos MV; Hulin C
    Semin Hematol; 2009 Apr; 46(2):133-42. PubMed ID: 19389497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial therapy in multiple myeloma: investigating the new treatment paradigm.
    Kettle JK; Finkbiner KL; Klenke SE; Baker RD; Henry DW; Williams CB
    J Oncol Pharm Pract; 2009 Sep; 15(3):131-41. PubMed ID: 19276138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of allogeneic stem cell transplantation in multiple myeloma.
    Bruno B; Giaccone L; Sorasio R; Boccadoro M
    Semin Hematol; 2009 Apr; 46(2):158-65. PubMed ID: 19389499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous stem cell transplantation in the elderly including pre- and post-treatment options.
    Kumar SK; Hayman SR; Kyle RA
    Bone Marrow Transplant; 2007 Dec; 40(12):1115-21. PubMed ID: 17680019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends in the management of newly diagnosed multiple myeloma.
    Reece DE
    Curr Opin Hematol; 2009 Jul; 16(4):306-12. PubMed ID: 19491669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.
    Tariman JD; Estrella SM
    Oncol Nurs Forum; 2005 Nov; 32(6):E127-38. PubMed ID: 16270103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to treat multiple myeloma - a representative multicentre treatment survey.
    Knauf W; Kellermann L; Poenisch W; Einsele H; Straka C; Frohn C; Goldschmidt H
    Onkologie; 2010; 33(11):604-10. PubMed ID: 20975307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country.
    Kumar L; Ghosh J; Ganessan P; Gupta A; Hariprasad R; Kochupillai V
    Bone Marrow Transplant; 2009 Mar; 43(6):481-9. PubMed ID: 18978818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of multiple myeloma and acute myelogenous leukemia in the elderly: an update.
    Zagonel V; Babare R; Spazzapan S; Rupolo M; Bordonaro R; Ferrara F; Pinto A
    Rays; 1997; 22(1 Suppl):30-6. PubMed ID: 9250011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of autologous transplantation in multiple myeloma].
    Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of thalidomide in previously untreated patients with multiple myeloma.
    Musto P; D'Auria F; Pietrantuono G; Bringhen S; Morabito F; Di Raimondo F; Pozzi S; Sacchi S; Boccadoro M; Palumbo A; ;
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1569-80. PubMed ID: 18925849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of multiple myeloma: the changing landscape.
    Reece DE
    Blood Rev; 2007 Nov; 21(6):301-14. PubMed ID: 17761373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
    Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M
    J Clin Oncol; 2009 Oct; 27(30):5001-7. PubMed ID: 19720903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.
    Spencer A; Prince HM; Roberts AW; Prosser IW; Bradstock KF; Coyle L; Gill DS; Horvath N; Reynolds J; Kennedy N
    J Clin Oncol; 2009 Apr; 27(11):1788-93. PubMed ID: 19273705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of the elderly multiple myeloma patients.
    Cavallo F; Ambrosini MT; Rus C; Boccadoro M; Palumbo A
    Leuk Lymphoma; 2007 Mar; 48(3):469-80. PubMed ID: 17454586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of high-dose therapy with autologous stem cell support in the era of novel agents.
    Attal M; Harousseau JL
    Semin Hematol; 2009 Apr; 46(2):127-32. PubMed ID: 19389496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.